AIMS/HYPOTHESIS: Non-alcoholic fatty liver disease (NAFLD) is associated with insulin resistance and characterised by different degrees of hepatic lesion. Its pathogenesis and correlation with apoptosis and insulin resistance in insulin target tissues remains incompletely understood. We investigated how insulin signalling, caspase activation and apoptosis correlate with different NAFLD stages in liver, muscle and visceral adipose tissues. METHODS: Liver, muscle and adipose tissue biopsies from 26 morbidly obese patients undergoing bariatric surgery were grouped according to the Kleiner-Brunt scoring system into simple steatosis, and less severe and more severe non-alcoholic steatohepatitis (NASH). Apoptosis was assessed by DNA fragmentation, and caspase-2 and -3 activation. Insulin signalling and c-Jun NH(2)-terminal kinase (JNK) proteins were evaluated by western blot. RESULTS: Caspase-3 and -2 activation, and DNA fragmentation were markedly increased in the liver of patients with severe NASH vs in that of those with simple steatosis (p < 0.01). Muscle tissue, and to a lesser extent the liver, had decreased tyrosine phosphorylated insulin receptor and insulin receptor substrate in patients with severe NASH, compared with those with simple steatosis (p < 0.01 muscle; p < 0.05 liver). Concomitantly, Akt phosphorylation decreased in muscle, liver and visceral adipose tissues in patients with severe NASH (at least p < 0.05). Finally, JNK phosphorylation was significantly increased in muscle (p < 0.01) and liver (p < 0.05) from NASH patients, compared with tissue from those with simple steatosis. CONCLUSIONS/ INTERPRETATION: Our results demonstrate a link between apoptosis, insulin resistance and different NAFLD stages, where JNK and caspase-2 may play a key regulatory role.
AIMS/HYPOTHESIS: Non-alcoholic fatty liver disease (NAFLD) is associated with insulin resistance and characterised by different degrees of hepatic lesion. Its pathogenesis and correlation with apoptosis and insulin resistance in insulin target tissues remains incompletely understood. We investigated how insulin signalling, caspase activation and apoptosis correlate with different NAFLD stages in liver, muscle and visceral adipose tissues. METHODS: Liver, muscle and adipose tissue biopsies from 26 morbidly obesepatients undergoing bariatric surgery were grouped according to the Kleiner-Brunt scoring system into simple steatosis, and less severe and more severe non-alcoholic steatohepatitis (NASH). Apoptosis was assessed by DNA fragmentation, and caspase-2 and -3 activation. Insulin signalling and c-Jun NH(2)-terminal kinase (JNK) proteins were evaluated by western blot. RESULTS:Caspase-3 and -2 activation, and DNA fragmentation were markedly increased in the liver of patients with severe NASH vs in that of those with simple steatosis (p < 0.01). Muscle tissue, and to a lesser extent the liver, had decreased tyrosine phosphorylated insulin receptor and insulin receptor substrate in patients with severe NASH, compared with those with simple steatosis (p < 0.01 muscle; p < 0.05 liver). Concomitantly, Akt phosphorylation decreased in muscle, liver and visceral adipose tissues in patients with severe NASH (at least p < 0.05). Finally, JNK phosphorylation was significantly increased in muscle (p < 0.01) and liver (p < 0.05) from NASH patients, compared with tissue from those with simple steatosis. CONCLUSIONS/ INTERPRETATION: Our results demonstrate a link between apoptosis, insulin resistance and different NAFLD stages, where JNK and caspase-2 may play a key regulatory role.
Authors: Rita M Ramalho; Helena Cortez-Pinto; Rui E Castro; Susana Solá; Adília Costa; Miguel C Moura; Maria E Camilo; Cecília M P Rodrigues Journal: Eur J Gastroenterol Hepatol Date: 2006-01 Impact factor: 2.566
Authors: Paulo S Ribeiro; Helena Cortez-Pinto; Susana Solá; Rui E Castro; Rita M Ramalho; Amélia Baptista; Miguel C Moura; Maria E Camilo; Cecília M P Rodrigues Journal: Am J Gastroenterol Date: 2004-09 Impact factor: 10.864
Authors: Guadalupe Sabio; Julie Cavanagh-Kyros; Hwi Jin Ko; Dae Young Jung; Susan Gray; John Y Jun; Tamera Barrett; Alfonso Mora; Jason K Kim; Roger J Davis Journal: Cell Metab Date: 2009-12 Impact factor: 27.287
Authors: André L Simão; Marta B Afonso; Pedro M Rodrigues; Margarida Gama-Carvalho; Mariana V Machado; Helena Cortez-Pinto; Cecília M P Rodrigues; Rui E Castro Journal: J Mol Med (Berl) Date: 2019-05-28 Impact factor: 4.599
Authors: Cindy X Cai; Hema Buddha; Shobha Castelino-Prabhu; Zhiwei Zhang; Robert S Britton; Bruce R Bacon; Brent A Neuschwander-Tetri Journal: Dig Dis Sci Date: 2017-02-13 Impact factor: 3.199
Authors: Faidon Magkos; Xiong Su; David Bradley; Elisa Fabbrini; Caterina Conte; J Christopher Eagon; J Esteban Varela; Elizabeth M Brunt; Bruce W Patterson; Samuel Klein Journal: Gastroenterology Date: 2012-03-13 Impact factor: 22.682
Authors: Sathish Kumar Natarajan; Sally A Ingham; Ashley M Mohr; Cody J Wehrkamp; Anuttoma Ray; Sohini Roy; Sophie C Cazanave; Mary Anne Phillippi; Justin L Mott Journal: Hepatology Date: 2014-06-20 Impact factor: 17.425
Authors: John Mach; Aniko Huizer-Pajkos; Alice Kane; Brett Jones; Catriona McKenzie; Sarah J Mitchell; Rafael de Cabo; Victoria C Cogger; David G Le Couteur; Sarah N Hilmer Journal: Exp Gerontol Date: 2015-04-22 Impact factor: 4.032
Authors: Duarte M S Ferreira; Marta B Afonso; Pedro M Rodrigues; André L Simão; Diane M Pereira; Pedro M Borralho; Cecília M P Rodrigues; Rui E Castro Journal: Mol Cell Biol Date: 2014-01-13 Impact factor: 4.272